12-Dec-2016
The Times of India
Doctors Without Borders/Medecins Sans Frontieres (MSF) and other health groups have reiterated concerns about harmful intellectual property provisions in the RCEP
12-Dec-2016
European Commission
As published by the European Commission
6-Dec-2016
The Jakarta Post
As trade negotiators from 16 countries gather in Indonesia to deliberate the terms of trade agreement — the Regional Comprehensive Economic Partnership agreement (RCEP), access to low-cost generic medicines is under grave threat.
25-Nov-2016
The Conversation
Trump tells a half truth about why the TPP is a bad deal
24-Nov-2016
Business Mirror
The launch of the Asean Economic Community (AEC) in December 2015 was a milestone for Asean economic integration, which is, however, an ongoing process.
22-Nov-2016
Huffington Post
Experts have been warning for years that Canada’s trade deal with the European Union would add billions to the cost of pharmaceuticals in Canada, but the government itself apparently did not study the issue.
27-Oct-2016
Electronic Frontier Foundation
The absence of support for open access in trade agreements comes as no surprise when considering that there are no representatives from the education sector, nor any library or archive representatives, in the relevant closed-door trade advisory committees
21-Oct-2016
Hindu Business Line
India and the US continued to differ on the issue of intellectual property rights (IPR) norms in their bilateral trade and investment policy discussions
13-Oct-2016
Don’t trade our lives away
Member countries must consider the impact of RCEP on access to medicines in developing countries
11-Oct-2016
South China Morning Post
Affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia